Search Within

Tiffany Chang

Formats
  1. Meeting Abstract (13)
  2. Journal Article (2)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (15)
  2. Department of Medicine (15)
  3. Hematologic Malignancies, Division of (15)
  4. Lymphoma (15)
  5. GME, Medicine (14)
  6. Graduate Medical Education (14)

More Groups

People
  1. Nivetha Ganesan (15)
  2. Alison Moskowitz (14)
  3. Robert Stuver (14)
  4. Steven Horwitz (12)
  5. Natasha Galasso (10)
  6. Santosha Vardhana (10)

More People

Years
  1. 2024 (9)
  2. 2023 (6)
  3. 2022 (1)
Publications
  1. Blood (13)
  2. Blood Advances (1)
  3. Haematologica (1)
  4. Science Translational Medicine (1)
Publishers
  1. American Society of Hematology (14)
  2. American Association for the Advancement of Science (1)
  3. Ferrata Storti Foundation (1)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes for patients with classical Hodgkin lymphoma who relapse after autologous stem cell transplant in the era of novel therapies
    Meeting Abstract

    Stuver, R.; Drill, E.; Ganesan, N.; Baron, K.; Casper, E.; Chang, T.; Desai, S. H.; Falade, A. S.; Galasso, N.; Herrera, A. F.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • PD-1 blockade before autologous stem cell transplantation improves outcomes in relapsed/refractory classic Hodgkin lymphoma: Results from a multicenter cohort
    Meeting Abstract

    Desai, S. H.; Merryman, R. W.; Shah, H.; Pederson, L. D.; Geyer, S. M.; Ganesan, N.; Chang, T.; Othman, T.; Falade, A. S.; Shah, G. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability
    Meeting Abstract

    Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
    Journal Article

    Wu, G.; Yoshida, N.; Liu, J.; Zhang, X.; Xiong, Y.; Heavican-Foral, T. B.; Mandato, E.; Liu, H.; Nelson, G. M.; Yang, L.; more...
    Science Translational Medicine (2023)

    Fulltext@MSK | Save
  • TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
    Journal Article

    Johnson, W. T.; Ganesan, N.; Epstein-Peterson, Z. D.; Moskowitz, A. J.; Stuver, R. N.; Maccaro, C. R.; Galasso, N.; Chang, T.; Khan, N.; Aypar, U.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Emapalumab for malignancy-associated hemophagocytic lymphohistiocytosis: The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Johnson, W. T.; Epstein-Peterson, Z. D.; Ganesan, N.; Chang, T.; Galasso, N.; Stuver, R.; Khan, N.; Salles, G.; Moskowitz, A. J.; Vardhana, S.; more...
    Blood (2022)

    Fulltext@MSK | Save